Revenue Exceeds Projection as COVID-19 Restrictions Eased
Authorization Backlog at Record Level of 120 Units, up 50% Sequentially
Conference call begins at 4:30 p.m. Eastern time today
CAMBRIDGE, Mass. (August 10, 2020) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced financial results for the three and six months ended June 30, 2020. Read more.